Professional Documents
Culture Documents
HCM Poster Final
HCM Poster Final
HCM Poster Final
Parasternal Strain
B-Mode 2D measurements end diastole. Strain Measure global longitudinal strain.
long axis LV IVS–end diastole. Record parametric ‘‘bull’s-eye’’ segmental strain
LV diameter–end diastole. map to assess for regional patterns in strain.
PW–end diastole. Regional longitudinal strain is reduced at sites of
hypertrophy and fibrosis.
Tips:
Measure only compacted myocardium (exclude RV structures). Tips:
Ensure apical views are not foreshortened.
Cross-reference with PSAX views.
Confirm that tracking is moving with the walls to
show areas of decreased strain.
Color Dopler Define level of obstruction with color Doppler. CW Doppler Evaluate and measure peak velocity across the
5C and 3C Tips: A4C tricuspid valve.
Set ROI to cover the entire LV from apex to the aortic
valve to define location of obstruction. B-Mode Perform routine LV exercise stress
Apical Views echocardiography views.
Compare the B-mode and color Doppler image
4C, 2C, 3C,
simultaneously to define the location of obstruction.
PLAX LV,
PSAC LV
Post-exercise
B-Mode Quickly evaluate for SAM.
5C, 3C UEA should not be used as the MV is the structure
of interest and it will not be seen with UEA.
*begin with the best view for evaluation of SAM
and LVOT gradient identified during rest imaging.
CW Doppler Quantify the severity of obstruction at rest.
5C and 3C CW Doppler measurement. Color Same as prior view.
Peak dynamic gradient. Doppler Set color Doppler ROI over the LV and LA to assess
Label, noting location of obstruction “e.g. resting LVOT gradient.” the level of obstruction and degree of MR.
Tips: This can be performed at the same time as the
B-mode imaging using Color Compare.
MR signal can contaminate the LVOT flow acceleration.
To evaluate for contamination, move the transducer more
CW Doppler Same as prior view.
laterally and angulate the probe to align the CW Doppler beam
post-exercise Place CW Doppler across the LVOT and measure
through the LVOT and aorta, avoiding the left atrium.
imaging the peak gradient.
Obtain and label LVOT jet then sweep the probe into the MR jet sequence
to highlight differences in velocities and Doppler profiles Perform as quickly as possible from the time
between the two jets. imaging begins using B-mode and color Doppler
data to align the Doppler beam.
If there is concern for contaminating MR, sweep the
Provocative Assess level of dynamic obstruction while patient performs a Doppler beam from the LVOT into the MR and label.
maneuvers provocative maneuver (Valsalva) in both the A5 and A3 chamber
B-mode and views
Color Doppler Tips:
5C and 3C
Practice the maneuver with the patient.
Define the best probe position to obtain optimal imaging during B-Mode (REPEAT using the second apical view)
provocation. 5C or 3C Quickly evaluate for SAM.
Record a cine clip while the maneuver is being performed with
B-mode and color Doppler to define whether SAM occurs/worsens Color (REPEAT using the second apical view)
or whether there is another location of worsening obstruction. Doppler Set color Doppler ROI over the LV and LA to assess
5C or 3C the imaging sequence level of obstruction and
Provocative degree of MR. This can be performed with B-mode
Quantify the severity of obstruction with provocation.
maneuvers imaging using Color Compare.
CW Doppler measurement:
CW Doppler
Peak dynamic gradient.
5C and 3C CW Doppler (REPEAT using the second apical view)
Label, noting location of obstruction and maneuver (e.g. LVOT 5C or 3C
gradient with Valsalva). Perform CW Doppler across the LVOT and
measure the peak gradient.
This piece was created from an article "A Practical Approach to Echocardiographic Imaging in Patients with Hypertrophic Cardiomyopathy" that was published in This product has been developed with support from Bristol Myers Squibb.
Access Additional
the Journal of the American Society of Echocardiography, September 2023 36(9) 913-932 © Соpyright 2024 The American Society of Echocardiography
Design by Ella Maru Studio ASE Hypertrophic
Authors of article: Carol C. Mitchell, PhD, ACS, RDMS, RDCS, RVT, RT(R); Cody Frye, BA, RDCS; Madeline Jankowski, BS, RDCS, ACS; John Symanski, MD; Steven J. Lester, M;,
Cardiomyopathy
Anna Woo, MD, SM; Yvonne Gilliland, MD; Andreea Dragulescu, MD; Theodore Abraham, MD; Milind Desai, MD; Matthew W. Martinez, MD; Sherif F. Nagueh, MD; and Dermot
Phelan, MD, PhD.
Resources